DIS-CHEM Pharmacies’ forecast of a 43.1% to 45.4% increase in headline earnings per share for the six months to August 31, 2022, saw its share price ratchet up 5.82% to R33.46 at the close of the JSE yesterday.
The pharmaceutical retailer courted controversy when chief executive Ivan Saltzman issued a memo to staff last month saying that the retailer, which has more than 20 000 employees, was falling behind on racial transformation targets at some level and would no longer be hiring whites, unless a special case was made to him or the head of human resources. Saltzman subsequently apologised for poor wording in the memo, but the group stood by its decision.
The group said in a trading statement yesterday, that headline earnings per share (Heps) was expected…
